TEVA logo

TEVA Cash From Investing

Annual CFI

$792.00 M
-$176.00 M-18.18%

December 31, 2024


Summary


Performance

TEVA Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTEVAcash flowmetrics:

Quarterly CFI

$202.00 M
-$66.00 M-24.63%

December 31, 2024


Summary


Performance

TEVA Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTEVAcash flowmetrics:

TTM CFI

$792.00 M
-$99.00 M-11.11%

December 31, 2024


Summary


Performance

TEVA TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTEVAcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

TEVA Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-18.2%+40.3%-14.9%
3 y3 years-48.0%+12.2%-9.5%
5 y5 years-41.5%+43.3%-8.2%

TEVA Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-48.0%+20.7%-33.1%+40.3%-48.0%+20.7%
5 y5-year-48.0%+20.7%-60.2%+43.3%-48.0%+20.7%
alltimeall time-77.0%+102.3%-89.4%+100.6%-78.6%+102.3%

Teva Pharmaceutical Industries Limited Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
$792.00 M(-18.2%)
$202.00 M(-24.6%)
$792.00 M(-11.1%)
Sep 2024
-
$268.00 M(+50.6%)
$891.00 M(+10.4%)
Jun 2024
-
$178.00 M(+23.6%)
$807.00 M(-13.3%)
Mar 2024
-
$144.00 M(-52.2%)
$931.00 M(-3.8%)
Dec 2023
$968.00 M(+47.6%)
$301.00 M(+63.6%)
$968.00 M(+15.9%)
Sep 2023
-
$184.00 M(-39.1%)
$835.00 M(+4.6%)
Jun 2023
-
$302.00 M(+66.9%)
$798.00 M(+18.0%)
Mar 2023
-
$181.00 M(+7.7%)
$676.00 M(+3.0%)
Dec 2022
$656.00 M(-56.9%)
$168.00 M(+14.3%)
$656.00 M(-10.6%)
Sep 2022
-
$147.00 M(-18.3%)
$734.00 M(-16.1%)
Jun 2022
-
$180.00 M(+11.8%)
$875.00 M(-25.6%)
Mar 2022
-
$161.00 M(-34.6%)
$1.18 B(-22.8%)
Dec 2021
$1.52 B(+76.5%)
$246.00 M(-14.6%)
$1.52 B(+7.4%)
Sep 2021
-
$288.00 M(-40.1%)
$1.42 B(+10.2%)
Jun 2021
-
$481.00 M(-5.3%)
$1.29 B(+15.0%)
Mar 2021
-
$508.00 M(+260.3%)
$1.12 B(+29.7%)
Dec 2020
$863.00 M(-36.3%)
$141.00 M(-10.2%)
$863.00 M(-25.1%)
Sep 2020
-
$157.00 M(-49.8%)
$1.15 B(-5.5%)
Jun 2020
-
$313.00 M(+24.2%)
$1.22 B(-8.7%)
Mar 2020
-
$252.00 M(-41.4%)
$1.33 B(-1.5%)
Dec 2019
$1.35 B(-27.4%)
$430.00 M(+92.0%)
$1.35 B(+35.6%)
Sep 2019
-
$224.00 M(-47.8%)
$999.00 M(-11.0%)
Jun 2019
-
$429.00 M(+57.7%)
$1.12 B(+2.1%)
Mar 2019
-
$272.00 M(+267.6%)
$1.10 B(-41.1%)
Dec 2018
$1.87 B(-45.9%)
$74.00 M(-78.7%)
$1.87 B(-49.6%)
Sep 2018
-
$347.00 M(-14.5%)
$3.70 B(+7.0%)
Jun 2018
-
$406.00 M(-60.9%)
$3.46 B(+16.6%)
Mar 2018
-
$1.04 B(-45.7%)
$2.97 B(-13.8%)
Dec 2017
$3.45 B(-110.0%)
$1.91 B(+1738.5%)
$3.45 B(+66.3%)
Sep 2017
-
$104.00 M(-220.9%)
$2.07 B(-106.8%)
Jun 2017
-
-$86.00 M(-105.7%)
-$30.33 B(-0.5%)
Mar 2017
-
$1.52 B(+181.8%)
-$30.47 B(-11.4%)
Dec 2016
-$34.41 B(+518.2%)
$538.00 M(-101.7%)
-$34.41 B(-2.4%)
Sep 2016
-
-$32.30 B(>+9900.0%)
-$35.24 B(+1047.4%)
Jun 2016
-
-$225.00 M(-90.7%)
-$3.07 B(-60.4%)
Mar 2016
-
-$2.42 B(+724.9%)
-$7.76 B(+39.5%)
Dec 2015
-$5.57 B(+283.8%)
-$293.00 M(+115.4%)
-$5.57 B(-1.0%)
Sep 2015
-
-$136.00 M(-97.2%)
-$5.62 B(-6.5%)
Jun 2015
-
-$4.92 B(+2145.2%)
-$6.01 B(+369.2%)
Mar 2015
-
-$219.00 M(-36.9%)
-$1.28 B(-11.7%)
Dec 2014
-$1.45 B(+26.4%)
-$347.00 M(-34.3%)
-$1.45 B(+2.2%)
Sep 2014
-
-$528.00 M(+182.4%)
-$1.42 B(+19.2%)
Jun 2014
-
-$187.00 M(-51.8%)
-$1.19 B(-6.2%)
Mar 2014
-
-$388.00 M(+22.8%)
-$1.27 B(+10.6%)
Dec 2013
-$1.15 B(+1.1%)
-$316.00 M(+5.7%)
-$1.15 B(-7.5%)
Sep 2013
-
-$299.00 M(+12.4%)
-$1.24 B(+4.2%)
Jun 2013
-
-$266.00 M(0.0%)
-$1.19 B(-1.3%)
Mar 2013
-
-$266.00 M(-35.0%)
-$1.21 B(+6.3%)
Dec 2012
-$1.13 B(-85.1%)
-$409.00 M(+64.3%)
-$1.13 B(-81.8%)
Sep 2012
-
-$249.00 M(-11.7%)
-$6.22 B(-13.2%)
Jun 2012
-
-$282.00 M(+45.4%)
-$7.16 B(+0.6%)
Mar 2012
-
-$194.00 M(-96.5%)
-$7.12 B(-6.3%)
Dec 2011
-$7.60 B
-$5.49 B(+359.9%)
-$7.60 B(+226.8%)
DateAnnualQuarterlyTTM
Sep 2011
-
-$1.19 B(+397.5%)
-$2.33 B(-62.7%)
Jun 2011
-
-$240.00 M(-64.5%)
-$6.23 B(+7.4%)
Mar 2011
-
-$676.00 M(+213.0%)
-$5.80 B(+6.4%)
Dec 2010
-$5.46 B(+495.5%)
-$216.00 M(-95.8%)
-$5.46 B(-0.9%)
Sep 2010
-
-$5.10 B(-2798.4%)
-$5.50 B(+645.5%)
Jun 2010
-
$189.00 M(-157.6%)
-$738.00 M(-33.0%)
Mar 2010
-
-$328.00 M(+24.7%)
-$1.10 B(+20.3%)
Dec 2009
-$916.00 M(-77.9%)
-$263.00 M(-21.7%)
-$916.00 M(-79.7%)
Sep 2009
-
-$336.00 M(+92.0%)
-$4.51 B(+4.2%)
Jun 2009
-
-$175.00 M(+23.2%)
-$4.33 B(-1.5%)
Mar 2009
-
-$142.00 M(-96.3%)
-$4.39 B(+6.2%)
Dec 2008
-$4.14 B(+205.8%)
-$3.86 B(+2403.9%)
-$4.14 B(+481.9%)
Sep 2008
-
-$154.00 M(-36.4%)
-$711.00 M(-9.0%)
Jun 2008
-
-$242.00 M(-310.4%)
-$781.00 M(+44.4%)
Mar 2008
-
$115.00 M(-126.7%)
-$541.00 M(-60.0%)
Dec 2007
-$1.35 B(-66.7%)
-$430.00 M(+92.0%)
-$1.35 B(+52.1%)
Sep 2007
-
-$224.00 M(>+9900.0%)
-$889.30 M(-28.3%)
Jun 2007
-
-$2.00 M(-99.7%)
-$1.24 B(-21.0%)
Mar 2007
-
-$697.00 M(-2168.2%)
-$1.57 B(-61.3%)
Dec 2006
-$4.06 B(+654.3%)
$33.70 M(-105.9%)
-$4.06 B(-1.7%)
Sep 2006
-
-$575.20 M(+73.0%)
-$4.13 B(+5.5%)
Jun 2006
-
-$332.50 M(-89.6%)
-$3.91 B(+7.0%)
Mar 2006
-
-$3.18 B(+8623.3%)
-$3.66 B(+579.9%)
Dec 2005
-$538.00 M(-77.5%)
-$36.50 M(-89.9%)
-$538.00 M(-42.6%)
Sep 2005
-
-$361.20 M(+375.3%)
-$936.70 M(+41.2%)
Jun 2005
-
-$76.00 M(+18.2%)
-$663.30 M(-17.3%)
Mar 2005
-
-$64.30 M(-85.2%)
-$801.70 M(-66.5%)
Dec 2004
-$2.39 B(+450.0%)
-$435.20 M(+395.7%)
-$2.39 B(+23.6%)
Sep 2004
-
-$87.80 M(-59.0%)
-$1.94 B(-5.9%)
Jun 2004
-
-$214.40 M(-87.1%)
-$2.06 B(+3.1%)
Mar 2004
-
-$1.66 B(-7591.4%)
-$1.99 B(+358.3%)
Dec 2003
-$435.10 M(-34.6%)
$22.10 M(-110.6%)
-$435.10 M(-11.0%)
Sep 2003
-
-$208.40 M(+36.8%)
-$488.80 M(-12.3%)
Jun 2003
-
-$152.30 M(+57.8%)
-$557.50 M(-6.0%)
Mar 2003
-
-$96.50 M(+205.4%)
-$593.20 M(-10.8%)
Dec 2002
-$664.90 M(+248.7%)
-$31.60 M(-88.6%)
-$664.90 M(-5.4%)
Sep 2002
-
-$277.10 M(+47.4%)
-$702.55 M(+51.1%)
Jun 2002
-
-$188.00 M(+11.8%)
-$464.92 M(+41.1%)
Mar 2002
-
-$168.20 M(+142.9%)
-$329.38 M(+72.8%)
Dec 2001
-$190.65 M(+126.1%)
-$69.25 M(+75.5%)
-$190.65 M(+57.0%)
Sep 2001
-
-$39.47 M(-24.8%)
-$121.40 M(+48.2%)
Jun 2001
-
-$52.46 M(+78.0%)
-$81.93 M(+178.0%)
Mar 2001
-
-$29.47 M
-$29.47 M
Dec 2000
-$84.31 M(-69.0%)
-
-
Dec 1999
-$271.87 M(+104.2%)
-
-
Dec 1998
-$133.11 M(+104.2%)
-
-
Dec 1997
-$65.20 M(-48.7%)
-
-
Dec 1996
-$127.00 M(-0.2%)
-
-
Dec 1995
-$127.30 M(+48.2%)
-
-
Dec 1994
-$85.90 M(+57.3%)
-
-
Dec 1993
-$54.60 M(+22.4%)
-
-
Dec 1992
-$44.60 M(-7.7%)
-
-
Dec 1991
-$48.30 M
-
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual cash flow from investing activities?
  • What is the all time high annual CFI for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual CFI year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly CFI year-on-year change?
  • What is Teva Pharmaceutical Industries Limited TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited TTM CFI year-on-year change?

What is Teva Pharmaceutical Industries Limited annual cash flow from investing activities?

The current annual CFI of TEVA is $792.00 M

What is the all time high annual CFI for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual cash flow from investing activities is $3.45 B

What is Teva Pharmaceutical Industries Limited annual CFI year-on-year change?

Over the past year, TEVA annual cash flow from investing activities has changed by -$176.00 M (-18.18%)

What is Teva Pharmaceutical Industries Limited quarterly cash flow from investing activities?

The current quarterly CFI of TEVA is $202.00 M

What is the all time high quarterly CFI for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly cash flow from investing activities is $1.91 B

What is Teva Pharmaceutical Industries Limited quarterly CFI year-on-year change?

Over the past year, TEVA quarterly cash flow from investing activities has changed by +$58.00 M (+40.28%)

What is Teva Pharmaceutical Industries Limited TTM cash flow from investing activities?

The current TTM CFI of TEVA is $792.00 M

What is the all time high TTM CFI for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM cash flow from investing activities is $3.70 B

What is Teva Pharmaceutical Industries Limited TTM CFI year-on-year change?

Over the past year, TEVA TTM cash flow from investing activities has changed by -$139.00 M (-14.93%)